Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 23Gastrointestinal 16Head & Neck 15Genitourinary 13Gynecologic 11CNS 6Tumor-Agnostic 5Thoracic 5Other hematologic neoplasm 5Sarcoma 4Lymphoid 4Other solid neoplasm 2Endocrine 2Dermatologic 2Plasma cell 1Classical hematology 1

Conditions

Cancer-related Venous Thromboembolism 1

Interventions

Cyclophosphamide 11fludarabine phosphate 9Whole-Body Irradiation 8Mycophenolic Acid 7Busulfan 6fludarabine 5Tacrolimus 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Rituximab 4Biopsy 4Azacitidine 4venetoclax 3apixaban 3Cyclosporine 3thymoglobulin 2decitabine and cedazuridine drug combination 2Vorinostat 2Vancomycin 2Tretinoin 2Specimen Handling 2Sirolimus 2Methotrexate 2Lenalidomide 2Injections 2Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Decitabine 2Cytarabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Surveys and Questionnaires × Classical hematology × 90 days × Clear all
NCT03407469 2026-05-20

Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

M.D. Anderson Cancer Center

Recruiting
260 enrolled
Classical hematology

Cancer-related Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡